TG Therapeutics Company Information

TG Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: TG Therapeutics, Inc.
  • Ticker: TGTX
  • Exchange: NasdaqCM
  • Founded: 1993
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$1.959b
  • Shares outstanding: 133.92m
  • Website:

Number of Employees


  • TG Therapeutics, Inc.
  • 2 Gansevoort Street
  • 9th Floor
  • New York
  • New York
  • 10014
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TGTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDDec 2011
NKB2DB (Deutsche Boerse AG)YesCommon StockDEEURDec 2011
0VGILSE (London Stock Exchange)YesCommon StockGBUSDDec 2011

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/28 00:00
End of Day Share Price2023/01/27 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.